Related Experiment Video
Updated: May 5, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
Predicting the Postoperative Recurrence Risk in Soft-Tissue Sarcomas of the Extremities and Trunk Using MRI-Based
Ruihuan Wang1, Shilong Wang2, Lei Xu1
1Department of Radiology, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), No.300 Guangzhou Road, Nanjing 210029, China (A.W., L.X., Y.W.).
Rationale And Objectives:
This study aims to develop a comprehensive nomogram for predicting the 3-year recurrence risk of patients with soft-tissue sarcoma (STS) undergoing surgical resection based on preoperative MRI images and clinical-radiological factors.
Materials And Methods:
202 patients with STS of the extremities and trunk who had undergone surgical resection were included from two centers. We extracted tumor and peritumoral radiomics features from contrast-enhanced T1-weighted imaging (CE-T1WI) and fat-saturated T2-weighted imaging (FS-T2WI) sequences to construct corresponding models, and used pre-trained VGG11 and ResNet18 networks to build sequence-specific deep learning models. A clinical-radiological model was built using selected clinical-radiological features. Finally, deep learning, tumor and peritumoral radiomics, and clinical-radiological analysis results were integrated to construct a comprehensive nomogram for systematic evaluation and analysis from multiple perspectives.
Results:
Among all STS patients, the 3-year postoperative recurrence rate was 47.52% (96/202). The nomogram showed excellent predictive performance, with AUC values of 0.874(95% confidence interval [CI]: 0.761-0.987) and 0.822 (95% CI: 0.707-0.938) in internal and external validation sets, respectively; its concordance index for 3-year recurrence risk prediction was 0.746 and 0.690 in the two sets. Kaplan-Meier curves demonstrated significant prognostic differences in patient stratification across all cohorts (log-rank test, all p < 0.01).
Conclusions:
The nomogram can predict the 3-year recurrence risk of patients, identify high-risk patients, and support personalized treatment.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025